Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.World Economyread more
Cryptocurrency fans will hope the futures contracts, which are federally regulated, can provide some much-needed legitimacy to bitcoin.Cryptocurrencyread more
Despite mixed fan and critic reactions to the final season of "Game of Thrones," the eight-season epic took home the top prize in the drama category at the Emmy Awards on...Entertainmentread more
There are alternative financial centers and investors can turn to Singapore, Tokyo or Shanghai if Hong Kong doesn't "shape up," says the founder and chairman of Citic Capital.Asia Economyread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Tensions between South Korea and Japan may ultimately disrupt the high-end tech sectors, says Heenam Choi, CEO at South Korea's sovereign wealth fund.Traderead more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
U.S. President Donald Trump's national security advisor said on Sunday that White House Asia policy adviser Matt Pottinger would become his top deputy.Politicsread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Datadog went public on Thursday and instantly hit a $10 billion valuation, becoming the fourth cloud software debut to reach that level this year.Technologyread more
Drugstore operator Walgreens Boots Alliance reported a better-than-expected quarterly profit, helped by cost cutting, and said it now expected its acquisition of Rite Aid to close on Jan. 27, three months later than planned.
Walgreens said in September it would likely have to divest between 500 and 1,000 stores to get regulatory clearance for the $9.4 billion deal.
Walgreens, the No. 1 U.S. drugstore operator by store count, had previously said it expected it would need to divest not more than 500 stores and that the deal would close on Oct. 27.
The company said it expected to divest stores to win approval for the deal by the end of 2016.
Supermarket chain Kroger is questioning whether to proceed with buying divested stores from Walgreens, a source familiar with the situation said on Wednesday, casting doubts on the future of the Walgreens-Rite Aid deal.
Kroger and Walgreens representatives declined to comment.
Walgreens wants to buy Rite Aid to widen its footprint in the United States and negotiate for lower drug costs.
Walgreens' shares were up 1.7 percent at $78.50 in premarket trading after closing at their lowest in five months on Wednesday. Rite Aid's shares were up about 4.4 percent at $6.95.
"The longer the (merger) process takes the more likely it is to close as it signals a delay in sorting out the divestiture package vs. a true blockage by FTC," Evercore ISI analyst Ross Muken wrote in a client note.
Walgreens said on Thursday its net income attributable to the company rose to $1.03 billion, or 95 cents per share, in the fourth quarter ended Aug. 31, from $26 million, or 2 cents per share, a year earlier.
The company had recorded a loss of $143 million on a previously held equity interest and $479 million in other expenses in the year-ago quarter.
Walgreens said it met its goal of achieving $1 billion in synergies in June from its Boots Alliance acquisition. It is also working on cutting $1.5 billion in costs by the end of its fiscal year ending in August 2017, including by closing about 200 stores and reorganizing operations, among other measures.
Excluding items, the company earned $1.07 per share in the quarter, beating the average analyst estimate of 99 cents per share, according to Thomson Reuters I/B/E/S.
Sales rose marginally to $28.64 billion, missing the average estimate of $29.06 billion.